Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 9, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 371,219 ordinary shares
- Purpose: Cancellation
- Highest Price Paid: 377.60 pence per share
- Lowest Price Paid: 370.00 pence per share
- Volume Weighted Average Price: 374.3158 pence per share
- Post-Transaction Share Capital: 9,128,753,699 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of 371,219 shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific market transaction in compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Investor Verification Checklist
- Verify the total number of shares purchased (371,219) and the weighted average price (374.3158 pence) against the company's full buyback programme progress.
- Confirm the updated registered share capital figure of 9,128,753,699 shares for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit metrics.